%0 Journal Article
%T Development and validation of a new questionnaire for the assessment of patients with diabetic foot disease: The Diabetic Foot Questionnaire (DiaFootQ).
%A Ruiz-Muñoz M
%A Fernández-Torres R
%A Formosa C
%A Gatt A
%A Pérez-Panero AJ
%A Pérez-Belloso AJ
%A Martínez-Barrios FJ
%A González-Sánchez M
%J Prim Care Diabetes
%V 0
%N 0
%D 2024 Jul 24
%M 39054234
%F 2.567
%R 10.1016/j.pcd.2024.07.002
%X <B>BACKGROUND: </B>The epidemiology data and global burden of diabetic foot disease underscores the need for effective prevention strategies, which requires an early diagnosis. Patient-reported outcome measures are instruments based on a simple format, which favours their application. Currently, there is an absence of instruments with a broad enough scope to capture the diverse aspects involved in diabetic foot disease.<BR><B>OBJECTIVE: </B>To develop a questionnaire for the assessment of patients with diabetic foot disease and carry out an analysis of its validity and reliability.<BR><B>METHODS: </B>The study was developed in two stages. Stage 1: the Delphi Panel was composed of 22 experts. The questionnaire is made up of 25 questions selected, after three rounds, from an initial sample of 68 questions. Stage 2: A validation study was performed. With a sample of 273 subjects, an exploratory factor analysis and an analysis of internal consistency, items response, and validity were carried out using the Diabetes Quality of Life, SF-12v2, Foot Function Index and EuroQol EQ5D questionnaires. Measurements of error and sensitivity to change were also analyzed.<BR><B>RESULTS: </B>A 25-item questionnaire (DiaFootQ) was developed. It comprised two dimensions: 1) lifestyle and function; and 2) footwear and foot self-care. Sample (n=273) mean age was 69.77 years (±11.08). The internal consistency of DiafootQ was α=0.916, and item response values were ICC=0.862-0.998. External validity correlation levels ranged from r=0.386 to r=0.888.<BR><B>CONCLUSIONS: </B>DiaFootQ was developed. Integrating the main aspects involved in diabetic foot disease could help to detect more accurately the risk or severity of these patients. DiaFootQ is a well-structured, valid, and reliable tool whose use should be promoted in clinical and research settings.